Literature DB >> 17873334

Genetic diagnosis of multiple affected tissues in a patient with McCune-Albright syndrome.

Ji Zhou1, Li-hao Sun, Bin Cui, Huai-dong Song, Xiao-ying Li, Guang Ning, Jian-min Liu.   

Abstract

McCune-Albright syndrome (MAS) is a sporadic disorder characterized by the classic triad of polyostotic fibrous dysplasia, café-au-lait' skin pigmentation, and hyperfunctional endocrinopathy. It is caused by embryonic somatic mutations leading to the substitution of His or Cys for Arg at amino acid 201 of the alpha-subunit of the signal transduction protein Gs (Gsalpha). A 32-year-old man was diagnosed as McCune-Albright syndrome with the following findings: polyostotic fibrous dysplasia, café-au-lait' spots and acromegaly. An ultrasonic examination showed that he had left-pleural effusion, which disappeared after almost a year without special treatment. Genomic DNA was isolated from the peripheral blood, bone tissue, skin lesion and pleura samples of the patient. Then PCR and direct sequencing were performed. An activating mutation of the Gsalpha gene (Arg201Cys) was found in the genomic DNA isolated from the peripheral blood and the bone tissue, but not in genomic DNA isolated from the skin and pleura samples.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17873334     DOI: 10.1007/s12020-007-0015-x

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  19 in total

1.  A rapid procedure for extracting genomic DNA from leukocytes.

Authors:  S W John; G Weitzner; R Rozen; C R Scriver
Journal:  Nucleic Acids Res       Date:  1991-01-25       Impact factor: 16.971

2.  Identification of a mutation in the gene encoding the alpha subunit of the stimulatory G protein of adenylyl cyclase in McCune-Albright syndrome.

Authors:  W F Schwindinger; C A Francomano; M A Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

3.  Polymerase chain reaction-based technique for the selective enrichment and analysis of mosaic arg201 mutations in G alpha s from patients with fibrous dysplasia of bone.

Authors:  G A Candeliere; P J Roughley; F H Glorieux
Journal:  Bone       Date:  1997-08       Impact factor: 4.398

4.  Idiopathic hypothalamic hypogonadotropic hypogonadism with polyostotic fibrous dysplasia.

Authors:  R Shires; M P Whyte; L V Avioli
Journal:  Arch Intern Med       Date:  1979-10

5.  Severe endocrine and nonendocrine manifestations of the McCune-Albright syndrome associated with activating mutations of stimulatory G protein GS.

Authors:  A Shenker; L S Weinstein; A Moran; O H Pescovitz; N J Charest; C M Boney; J J Van Wyk; M J Merino; P P Feuillan; A M Spiegel
Journal:  J Pediatr       Date:  1993-10       Impact factor: 4.406

6.  Hypersecretion of growth hormone and prolactin in McCune-Albright syndrome.

Authors:  L Cuttler; J A Jackson; M Saeed uz-Zafar; L L Levitsky; R C Mellinger; L A Frohman
Journal:  J Clin Endocrinol Metab       Date:  1989-06       Impact factor: 5.958

7.  Activating Gsalpha mutations: analysis of 113 patients with signs of McCune-Albright syndrome--a European Collaborative Study.

Authors:  Serge Lumbroso; Françoise Paris; Charles Sultan
Journal:  J Clin Endocrinol Metab       Date:  2004-05       Impact factor: 5.958

Review 8.  Acromegaly with fibrous dysplasia: McCune-Albright Syndrome -- clinical studies in 3 cases and brief review of literature--.

Authors:  Anil Bhansali; Bhawani S Sharma; Polupoina Sreenivasulu; Paramjit Singh; Rakesh K Vashisth; Radharaman J Dash
Journal:  Endocr J       Date:  2003-12       Impact factor: 2.349

9.  The McCune-Albright syndrome: a lethal gene surviving by mosaicism.

Authors:  R Happle
Journal:  Clin Genet       Date:  1986-04       Impact factor: 4.438

10.  A novel GNAS1 mutation, R201G, in McCune-albright syndrome.

Authors:  M Riminucci; L W Fisher; A Majolagbe; A Corsi; R Lala; C De Sanctis; P G Robey; P Bianco
Journal:  J Bone Miner Res       Date:  1999-11       Impact factor: 6.741

View more
  4 in total

Review 1.  Acromegaly and McCune-Albright syndrome.

Authors:  Sylvie Salenave; Alison M Boyce; Michael T Collins; Philippe Chanson
Journal:  J Clin Endocrinol Metab       Date:  2014-02-11       Impact factor: 5.958

2.  Treatment protocols for growth hormone-secreting pituitary adenomas combined with craniofacial fibrous dysplasia: A case report of atypical McCune-Albright syndrome.

Authors:  Jia Xu; Xi Li; Chang-Sheng Lv; Ying Chen; Meng Wang; Jian-Feng Liu; Lai Gui
Journal:  Exp Ther Med       Date:  2014-06-19       Impact factor: 2.447

3.  Hypothyroidism in McCune-Albright Syndrome and Role of Bone Scan in Management of Fibrous Dysplasia: An Unusual Case Scenario with Review of Literature.

Authors:  Narvesh Kumar; Subhash Chand Kheruka; Rani Kunti R Singh; Mudalsha Ravina; Deepanksha Dutta; Sanjay Gambhir
Journal:  Indian J Nucl Med       Date:  2017 Jan-Mar

4.  Radioiodine treatment in McCune-Albright syndrome with hyperthyroidism.

Authors:  Dhritiman Chakraborty; Bhagwant Rai Mittal; Raghava Kashyap; Kuruva Manohar; Anish Bhattacharya; Anil Bhansali
Journal:  Indian J Endocrinol Metab       Date:  2012-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.